Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Sahler, Julie ^a   Woeller, Collynn F ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; CD11B ANTIGEN; FIBRONECTIN; INTERLEUKIN 8; MATRIX PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTOME; CCL2 PROTEIN, HUMAN; INTEGRIN; ITGAM PROTEIN, HUMAN;

ARTICLE; BIOCHEMICAL COMPOSITION; CELL ADHESION; CELL COMPOSITION; CELL ENGINEERING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MEGAKARYOCYTE; MEMBRANE MICROPARTICLE; MONOCYTE; PARTICLE SIZE; PERIPHERAL BLOOD MONONUCLEAR CELL; PPARGAMMA GENE; PROTEIN EXPRESSION; PROVOCATION; SPECTROPHOTOMETER; UPREGULATION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CYTOLOGY; ENDOCYTOSIS; GENETICS; INFLAMMATION; METABOLIC ENGINEERING; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS);

ANTIGENS, CD11B; CELL ADHESION; CELL LINE; CELL-DERIVED MICROPARTICLES; CHEMOKINE CCL2; ENDOCYTOSIS; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTEGRINS; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MEGAKARYOCYTES; METABOLIC ENGINEERING; MONOCYTES; PPAR GAMMA; PRIMARY CELL CULTURE; RNA, MESSENGER;

EID: 84913534804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113189     Document Type: Article

References (22)

1. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ (2006) Membranederived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495.
2. Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, et al. (2009) Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 113: 1112-1121.
3. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovasc Res 59: 277-287.
4. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, et al. (2005) Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 52: 3337-3348.
5. Norling LV, Dalli J (2013) Microparticles are novel effectors of immunity. Curr Opin Pharmacol 13: 570-575.
6. György B, Szabó TG, Pásztó i M, Pá l Z, Misják P, et al. (2011) Membrane vesicles, current state-of-theart: emerging role of extracellular vesicles. Cell Mol Life Sci 68: 2667-2688.
7. Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, et al. (2008) Peroxisome proliferatoractivated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 99: 86-95.
8. Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, et al. (2004) Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 104: 1361-1368.
9. Sahler J, Woeller C, Spinelli S, Blumberg N, Phipps R (2012) A novel method for overexpression of peroxisome proliferator-activated receptor-c in megakaryocyte and platelet microparticles achieves transcellular signaling. J Thromb Haemost 10: 2563-2572.
10. Garcia-Bates TM, Bernstein SH, Phipps RP (2008) Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clin Cancer Res 14: 6414-6425.
11. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78: 838-848.
12. Xu Y, Nakane N, Maurer-Spurej E (2011) Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 51: 363-370.
13. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
14. Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, et al. (2001) High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 158: 277-287.
15. Nicholson AC, Hajjar DP (2004) CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascul Pharmacol 41: 139-146.
16. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
17. Huo Y, Hafezi-Moghadam A, Ley K (2000) Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res 87: 153-159.
18. White ES, Livant DL, Markwart S, Arenberg DA (2001) Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependent angiogenic activity. J Immunol 167: 5362-5366.
19. Takizawa T, Nishinarita S, Kitamura N, Hayakawa J, Kang H, et al. (1995) Interaction of the cellbinding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes. Clin Exp Immunol 101: 376-382.
20. Liu H, Shi B, Huang CC, Eksarko P, Pope RM (2008) Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett 117: 70-80.
21. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, et al. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42: 1530-1536.
22. Li B, Pozzi A, Young PP (2011) TNFalpha accelerates monocyte to endothelial transdifferentiation in tumors by the induction of integrin alpha5 expression and adhesion to fibronectin. Mol Cancer Res 9: 702-711.